pulmonologyadvisor2d
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
The US FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.
Monthly Prescribing Reference4d
Symbravo Approved for Acute Treatment of Migraine With or Without Aura
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.